BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31321924)

  • 1. Does the Tempo and Pattern of Neurological Syndrome Help Diagnose Paraneoplastic Etiology?
    Ojha P; Jagiasi K; Chheda A; Soni G; Peddawad D; Kadam N; Patil S
    J Assoc Physicians India; 2018 Sep; 66(9):14-18. PubMed ID: 31321924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes.
    Honnorat J
    Acta Neurol Scand Suppl; 2006; 183():64-8. PubMed ID: 16637934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes.
    Villagrán-García M; Farina A; Campetella L; Arzalluz-Luque J; Honnorat J
    Rev Neurol (Paris); 2024; 180(1-2):107-116. PubMed ID: 38142198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
    Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
    Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
    Stich O; Rauer S
    Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
    Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
    [No Abstract]   [Full Text] [Related]  

  • 15. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommended diagnostic criteria for paraneoplastic neurological syndromes.
    Graus F; Delattre JY; Antoine JC; Dalmau J; Giometto B; Grisold W; Honnorat J; Smitt PS; Vedeler Ch; Verschuuren JJ; Vincent A; Voltz R
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1135-40. PubMed ID: 15258215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.